Live feed17:58:43·498dINSIDERFilingvia QuantisnowAmendment: SVP, Chief Scientific Officer Belvin Marcia was granted 92,500 shares, increasing direct ownership by 53% to 268,148 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CTMX· CytomX Therapeutics Inc.Health CareOriginal source
